| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.092 | 0.4 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.4 |